International Journal of Cancer Management

Published by: Kowsar

Comparison of Outcome between Invasive Lobular Carcinoma (ILC) and Invasive Ductal Carcinoma (IDC) Patients Treating with Breast Conserving Surgery (BCS) and Radical Dose of Intraoperative Electron Radiotherapy (IOERT)

Azam Salati 1 , * , Mohammad Esmaeil Akbari 1 , ** , Nahid Nafissi 2 , Sajad Noorian 3 , Seyed Rabie Mahdavi 2 , Hamid Reza Mirzaei 1 , Hassan Moayeri 1 , Zeinab Shormeij 1 , Mahdieh Tutuni 1 , Najmeh Saberi 1 and Minoo Shahani 1
Authors Information
1 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Cancer Research Center, Iran University of Medical Sciences, Tehran, Iran
3 Department of Statistics, Faculty of Science, University of Qom, Qom, Iran
Corresponding Authors:
Article information
  • International Journal of Cancer Management: November 2018, 11 (11); e80985
  • Published Online: November 11, 2018
  • Article Type: Research Article
  • Received: June 18, 2018
  • Revised: September 3, 2018
  • Accepted: September 23, 2018
  • DOI: 10.5812/ijcm.80985

To Cite: Salati A, Akbari M E, Nafissi N, Noorian S , Mahdavi S R , et al. Comparison of Outcome between Invasive Lobular Carcinoma (ILC) and Invasive Ductal Carcinoma (IDC) Patients Treating with Breast Conserving Surgery (BCS) and Radical Dose of Intraoperative Electron Radiotherapy (IOERT), Int J Cancer Manag. 2018 ; 11(11):e80985. doi: 10.5812/ijcm.80985.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005;93(9):1046-52. doi: 10.1038/sj.bjc.6602787. [PubMed: 16175185]. [PubMed Central: PMC2361680].
  • 2. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: Tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6(3):R149-56. doi: 10.1186/bcr767. [PubMed: 15084238]. [PubMed Central: PMC400666].
  • 3. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252-71. doi: 10.3322/caac.21235. [PubMed: 24890451].
  • 4. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7-30. doi: 10.3322/caac.21332. [PubMed: 26742998].
  • 5. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. New Engl J Med. 2002;347(8):567-75. doi: 10.1056/NEJMoa020128.
  • 6. Litiere S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR, Van Limbergen E, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412-9. doi: 10.1016/S1470-2045(12)70042-6. [PubMed: 22373563].
  • 7. Agarwal S, Pappas L, Neumayer L, Kokeny K, Agarwal J. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg. 2014;149(3):267-74. doi: 10.1001/jamasurg.2013.3049. [PubMed: 24429935].
  • 8. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513-20. doi: 10.1056/NEJMoa0906260. [PubMed: 20147717].
  • 9. Cornford EJ, Wilson AR, Athanassiou E, Galea M, Ellis IO, Elston CW, et al. Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: A comparative analysis. Br J Radiol. 1995;68(809):450-3. doi: 10.1259/0007-1285-68-809-450. [PubMed: 7788227].
  • 10. Helvie MA, Paramagul C, Oberman HA, Adler DD. Invasive lobular carcinoma. Imaging features and clinical detection. Invest Radiol. 1993;28(3):202-7. [PubMed: 8486484].
  • 11. Gage I, Recht A, Gelman R, Nixon AJ, Silver B, Bornstein BA, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33(2):245-51. doi: 10.1016/0360-3016(95)02001-R. [PubMed: 7673011].
  • 12. Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383(9917):603-13. doi: 10.1016/S0140-6736(13)61950-9. [PubMed: 24224997].
  • 13. Bharat A, Gao F, Margenthaler JA. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers. Am J Surg. 2009;198(4):516-9. doi: 10.1016/j.amjsurg.2009.06.005. [PubMed: 19800459].
  • 14. Arpino G, Bardou VJ, Clark GM, M Elledge R. Infiltrating lobular carcinoma of the breast: Tumor characteristics and clinical outcome. Breast Cancer Res. 2004:6:R149. doi: 10.1186/bcr767.
  • 15. Polgar C, Van Limbergen E, Potter R, Kovacs G, Polo A, Lyczek J, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010;94(3):264-73. doi: 10.1016/j.radonc.2010.01.014. [PubMed: 20181402].
  • 16. Correa C, Harris EE, Leonardi MC, Smith BD, Taghian AG, Thompson AM, et al. Accelerated partial breast irradiation: Executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol. 2017;7(2):73-9. doi: 10.1016/j.prro.2016.09.007. [PubMed: 27866865].
  • 17. Leonardi MC, Ricotti R, Dicuonzo S, Cattani F, Morra A, Dell'Acqua V, et al. From technological advances to biological understanding: The main steps toward high-precision RT in breast cancer. Breast. 2016;29:213-22. doi: 10.1016/j.breast.2016.07.010. [PubMed: 27542556].
  • 18. Vaidya JS, Wenz F, Tobias JS. Trial supports targeted radiotherapy for early breast cancer but protocol still requires 3 weeks of daily therapy. BMJ Evid Based Med. 2018;23(1):38-9. doi: 10.1136/ebmed-2017-110849. [PubMed: 29367327].
  • 19. Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): A randomised controlled equivalence trial. Lancet Oncol. 2013;14(13):1269-77. doi: 10.1016/S1470-2045(13)70497-2. [PubMed: 24225155].
  • 20. Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: A randomised, phase 3, non-inferiority trial. Lancet. 2016;387(10015):229-38. doi: 10.1016/S0140-6736(15)00471-7. [PubMed: 26494415].
  • 21. Leonardi MC, Maisonneuve P, Mastropasqua MG, Cattani F, Fanetti G, Morra A, et al. Comparison of treatment outcome between invasive lobular and ductal carcinomas in patients receiving partial breast irradiation with intraoperative electrons. Int J Radiat Oncol Biol Phys. 2017;99(1):173-81. doi: 10.1016/j.ijrobp.2017.04.033. [PubMed: 28816144].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments